Volume 25, Number 3—March 2019
Research
Multicenter Study of Cronobacter sakazakii Infections in Humans, Europe, 2017
Table 2
Characteristics of patients enrolled and Cronobacter sakazakii isolates collected in a multicenter study of C. sakazakii infections in humans, Europe, 2017*
Sample ID | Country of origin | Patient age, y/sex | Specimen source | Death within 30 d | MLST |
---|---|---|---|---|---|
802520 | Austria | 73/F | Stool | No | 630 |
7750-17 | Austria | <1/M | Blood | Yes | 4 |
16862-17 | Austria | 77/F | Blood | No | 37 |
808921 | Austria | 69/F | Stool | No | 21 |
56487-17 | Austria | 78/M | Urine | No | 17 |
101807-17 | Austria | 77/M | Blood | No | 1 |
9929-17 | Austria | 5/M | Stool | No | 17 |
EUCRONI016 | Belgium | 61/M | Urine | No | 13 |
EUCRONI012 | Belgium | 78/M | Wound | No | 31 |
1481-17 | Czech Republic | 80/F | Rectal swab | No | 8 |
436-17 | Czech Republic | 31/M | Rectal swab | No | 4 |
10965-17 | Czech Republic | 74/M | Rectal swab | No | 4 |
D97986 | Denmark | 85/F | Sputum | No | 1 |
17007483 | Denmark | 69/M | Urine | No | 58 |
423410 | Ireland | 65/M | Blood | No | 12 |
170215-0130 | Norway | 87/M | Blood | Yes | 17 |
M732000 | Portugal | 60/M | Urine | No | 40 |
80357408-17 | Scotland | 73/F | Stool | No | 33 |
80363028-17 | Scotland | 71/M | Urine | No | 4 |
07_2005 | Slovenia | 54/M | Tracheal aspirate | No | 184 |
2017C1 | Switzerland | 55/F | Cervix uteri | No | 40 |
*MLST, multilocus sequence type.
1Members of the EUCRONI study group are listed at the end of this article.
Page created: February 19, 2019
Page updated: February 19, 2019
Page reviewed: February 19, 2019
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.